Literature DB >> 11161291

Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay.

K A Tubbs1, D Nedelkov, R W Nelson.   

Abstract

The use of mass spectrometric immunoassay (MSIA) in analyzing beta-2-microglobulin (beta(2)m) present in human biological fluids (tears, saliva, plasma, and urine) is described. Pipettor tips containing porous affinity frits, derivatized with polyclonal anti-beta(2)m immunoglobulin, were manufactured and used to selectively isolate and concentrate beta(2)m from the biofluids, after which matrix-assisted laser desorption/ionization time-of-flight mass spectrometry was used to detect beta(2)m unambiguously at its characteristic molecular mass. The affinity tips were found rapid to use, requiring approximately 15 min per analysis, and exhibited low nonspecific binding properties that yielded essentially interference-free analyses. The beta(2)m MSIA was made quantitative by inclusion of an internal standard into the analysis for signal normalization. The resulting assay had a Linear dynamic range (R(2) = 0.983) covering a beta(2)m concentration range of 0.010-1.0 mg/L with a standard error of approximately 5%. In application, urine samples from healthy individuals were screened and compared with sample from an individual suffering from renal infection. Results indicated an approximately 30-fold increase in beta(2)m levels in samples taken from the infected individual. During the screening, MSIA was able to distinguish between wild-type and glycosylated forms of beta(2)m, which made possible the accurate quantification of wild-type beta(2)m without interference from glycosylated versions of the protein. These results demonstrate a new approach to the rapid and accurate detection/quantification of beta(2)m present in biological fluids. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161291     DOI: 10.1006/abio.2000.4921

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay.

Authors:  Qin Yang; Iratxe Eskurza; Urban A Kiernan; David A Phillips; Matthias Blüher; Timothy E Graham; Barbara B Kahn
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

2.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

3.  Mass spectrometric immunoassay for quantitative determination of protein biomarker isoforms.

Authors:  Olgica Trenchevska; Elena Kamcheva; Dobrin Nedelkov
Journal:  J Proteome Res       Date:  2010-09-23       Impact factor: 4.466

4.  Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells.

Authors:  Takayuki Shiratsuchi; Jonathan Schneck; Akira Kawamura; Moriya Tsuji
Journal:  J Immunol Methods       Date:  2009-04-15       Impact factor: 2.303

5.  Glycosylation status of vitamin D binding protein in cancer patients.

Authors:  Douglas S Rehder; Randall W Nelson; Chad R Borges
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

6.  Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants.

Authors:  Urban A Kiernan; David A Phillips; Olgica Trenchevska; Dobrin Nedelkov
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

Review 7.  Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Proteomes       Date:  2016-03-17

8.  Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators.

Authors:  Frank Klont; Nick H T Ten Hacken; Péter Horvatovich; Stephan J L Bakker; Rainer Bischoff
Journal:  Anal Chem       Date:  2017-05-10       Impact factor: 6.986

9.  Detection of PCT and urinary β2 -MG enhances the accuracy for localization diagnosing pediatric urinary tract infection.

Authors:  Jian Fang; Jiangwei Luan; Gaohong Zhu; Chang Qi; Dandan Wang
Journal:  J Clin Lab Anal       Date:  2016-11-01       Impact factor: 2.352

10.  Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.

Authors:  Eric E Niederkofler; David A Phillips; Bryan Krastins; Vathany Kulasingam; Urban A Kiernan; Kemmons A Tubbs; Scott M Peterman; Amol Prakash; Eleftherios P Diamandis; Mary F Lopez; Dobrin Nedelkov
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.